Amanote Research
Register
Sign In
Antiemetic Effect of Nonabine in Cancer Chemotherapy
BMJ
doi 10.1136/bmj.286.6374.1352
Full Text
Open PDF
Abstract
Available in
full text
Date
April 23, 1983
Authors
V. J Harvey
M. L Slevin
P. F M Wrigley
Publisher
BMJ
Related search
Antiemetic Activity of Ginger in Childrenreceiving Cancer Chemotherapy
Annals of the College of Medicine, Mosul
Evaluation of Antiemetic Therapy in Different Cancer Chemotherapy Regimen
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
Audit of Antiemetic Drug Prescription and Their Effect in Ameliorating Nausea and Vomiting in People Undergoing Curative Chemotherapy for Their Cancer: Observations From a Tertiary Care Centre
International Journal of Medical Laboratory Research
Real-World Effectiveness of Palonosetron-Based Antiemetic Regimens: Preventing Chemotherapy-Induced Nausea and Vomiting
Journal of Comparative Effectiveness Research
Health Policy
Antiemetics for Chemotherapy-Induced Nausea and Vomiting Occurring Despite Prophylactic Antiemetic Therapy
Journal of Palliative Medicine
Medicine
Anesthesiology
Pain Medicine
Nursing
Genetic Effect of Chemotherapy Exposure in Children of Testicular Cancer Survivors
Clinical Cancer Research
Cancer Research
Oncology
Potential Synergistic Effect of Phosphodiesterase Inhibitors With Chemotherapy in Lung Cancer
Journal of Cancer
Oncology
Efficacy of Triple Antiemetic Therapy (Palonosetron, Dexamethasone, Aprepitant) for Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Carboplatin-Based, Moderately Emetogenic Chemotherapy.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Pharmacoeconomic Analysis of Using Aprepitant Plus Standard Antiemetic Therapy for Prevention of Nausea and Vomiting Associated With Highly and Moderately Emetogenic Cancer Chemotherapy in Russia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
